Detalhe da pesquisa
1.
Next-generation sequencing of circulating tumor DNA for metastatic non-small cell lung cancer: a discussion on its implementation in the Brazilian clinical practice.
Future Oncol
; 17(2): 205-213, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33052747
2.
Patient-centered outcomes in non-small-cell lung cancer: a real-world perspective.
Future Oncol
; 17(14): 1721-1733, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33626916
3.
Defining a standard set of patient-centred outcomes for lung cancer.
Eur Respir J
; 48(3): 852-60, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27390281
4.
Stage III Non-Small-Cell Lung Cancer Treated With Concurrent Chemoradiation Followed or Not by Consolidation Chemotherapy: A Survival Analysis From a Brazilian Multicentric Cohort.
J Glob Oncol
; 4: 1-11, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30241276
5.
Padrões de tratamento, uso de recursos e custo do câncer de pulmão de não pequenas células avançado em instituições brasileiras privadas / Treatment patterns, resource use and cost-of-illness of advanced non-small lung cancer in Brazilian private institutions
J. bras. econ. saúde (Impr.)
; 10(2): 86-106, Agosto/2018.
Artigo
Português
| LILACS, ECOS | ID: biblio-914919
6.
Erlotinib in symptomatic brain metastases from a lung adenocarcinoma with a sensitizing EGFR mutation.
J Thorac Oncol
; 7(6): 1059-60, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22588158